LifeMD Profit Margin 2011-2025 | LFMD
Current and historical gross margin, operating margin and net profit margin for LifeMD (LFMD) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. LifeMD net profit margin as of March 31, 2025 is -4.58%.
| LifeMD Annual Profit Margins |
|---|
| LifeMD Quarterly Profit Margins |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.522B | $0.212B |
| LifeMD Inc. is a telehealth company. It offers a full portfolio of direct-to-patient products and services. The company combines virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers. LifeMD Inc., formerly known as Conversion Labs, is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $136.314B | 25.57 |
| Elevance Health (ELV) | United States | $85.975B | 11.09 |
| CVS Health (CVS) | United States | $79.418B | 9.87 |
| Cencora (COR) | United States | $56.343B | 19.60 |
| DiDi Global (DIDIY) | China | $22.968B | 34.86 |
| Natera (NTRA) | United States | $21.581B | 0.00 |
| BioMerieux (BMXMF) | France | $15.705B | 0.00 |
| Solventum (SOLV) | United States | $12.562B | 13.30 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.357B | 0.00 |
| CochLear (CHEOY) | Australia | $11.324B | 0.00 |
| Revvity (RVTY) | United States | $10.833B | 18.64 |
| ICON (ICLR) | Ireland | $10.585B | 9.84 |
| Viatris (VTRS) | United States | $10.364B | 3.56 |
| Doximity (DOCS) | United States | $9.697B | 45.17 |
| Avantor (AVTR) | United States | $8.886B | 12.91 |
| HealthEquity (HQY) | United States | $8.734B | 42.97 |
| Medpace Holdings (MEDP) | United States | $8.538B | 22.68 |
| Sonic Healthcare (SKHHY) | Australia | $8.205B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.763B | 13.25 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 27.18 |
| Bausch + Lomb (BLCO) | Canada | $4.142B | 24.42 |
| BrightSpring Health Services (BTSG) | United States | $4.077B | 37.74 |
| Sotera Health (SHC) | United States | $3.514B | 19.97 |
| Alignment Healthcare (ALHC) | United States | $2.948B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.922B | 38.00 |
| Concentras Parent (CON) | United States | $2.767B | 15.99 |
| Organon (OGN) | United States | $2.480B | 2.64 |
| Ardent Health Partners (ARDT) | United States | $2.103B | 8.96 |
| GeneDx Holdings (WGS) | United States | $1.997B | 76.90 |
| Premier (PINC) | United States | $1.891B | 14.36 |
| Progyny (PGNY) | United States | $1.829B | 40.26 |
| PACS (PACS) | United States | $1.513B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.361B | 27.21 |
| Teladoc Health (TDOC) | United States | $1.225B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.222B | 9.30 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.003B | 0.00 | |
| Agilon Health (AGL) | United States | $0.923B | 0.00 |
| CareDx (CDNA) | United States | $0.922B | 14.40 |
| Nutex Health (NUTX) | United States | $0.921B | 13.91 |
| AMN Healthcare Services Inc (AMN) | United States | $0.807B | 7.56 |
| QDM (QDMI) | Hong Kong, SAR China | $0.743B | 0.00 |
| Embecta (EMBC) | United States | $0.611B | 4.12 |
| InnovAge Holding (INNV) | United States | $0.547B | 0.00 |
| Enhabit (EHAB) | United States | $0.523B | 43.04 |
| Auna S.A (AUNA) | Luxembourg | $0.482B | 10.85 |
| SBC Medicals (SBC) | United States | $0.482B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.461B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.387B | 0.00 |
| Oncology Institute (TOI) | United States | $0.286B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.224B | 0.00 |
| Beauty Health (SKIN) | United States | $0.203B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| DocGo (DCGO) | United States | $0.139B | 22.67 |
| KindlyMD (NAKA) | United States | $0.135B | 0.00 |
| OncoCyte (OCX) | United States | $0.093B | 0.00 |
| So-Young (SY) | China | $0.093B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.069B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.048B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.039B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.032B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.019B | 0.00 |
| ModivCare (MODV) | United States | $0.019B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |